Mcminnville Dialysis Clinic is a medicare approved dialysis facility center in Mcminnville, Tennessee and it has 17 dialysis stations. It is located in Warren county at 1524 Sparta Street, Mcminnville, TN, 37110. You can reach out to the office of Mcminnville Dialysis Clinic at (931) 507-5700. This dialysis clinic is managed and/or owned by Diversified Specialty Institutes (dsi). Mcminnville Dialysis Clinic has the following ownership type - Profit. It was first certified by medicare in March, 2006. The medicare id for this facility is 442663 and it accepts patients under medicare ESRD program.
| Name | Mcminnville Dialysis Clinic |
|---|---|
| Location | 1524 Sparta Street, Mcminnville, Tennessee |
| No. of Dialysis Stations | 17 |
| Medicare ID | 442663 |
| Managed By | Diversified Specialty Institutes (dsi) |
| Ownership Type | Profit |
| Late Shifts | No |
| 1524 Sparta Street, Mcminnville, Tennessee, 37110 | |
| (931) 507-5700 | |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
| NPI Number | 1982641825 |
| Organization Name | U.s. Renal Care Mcminnville Dialysis |
| Doing Business As | Nra Mcminnville Tennessee Llc |
| Address | 1524 Sparta St Mc Minnville, Tennessee, 37110 |
| Phone Number | (931) 507-5700 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
| NPI Number | 1215293956 |
| Organization Name | Dsi Mcminnville Dialysis |
| Doing Business As | Nra Mcminnville Tennessee Llc |
| Address | 1524 Sparta St Mcminnville, Tennessee, 37110 |
| Phone Number | (931) 507-5700 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 21 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 40 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 310 |
| Percentage of adult patients getting regular hemodialysis at the center | 99 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
| Adult patients getting regular peritoneal dialysis at the center | 18 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 160 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 96 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Mcminnville Dialysis Clinic with elevated calcium levels.
| Patients with hypercalcemia | 54 |
| Hypercalcemia patient months | 474 |
| Patients with Serumphosphor | 58 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 34 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 13 |
| Patients with Serumphosphor greater than 7 mg/dL | 7 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 31 |
| Patient months included in arterial venous fistula and catheter summaries | 237 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 78 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 3 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 52 |
| Hospitalization Rate in facility | 188.3 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 329.3 |
| Hospitalization Rate: Lower Confidence Limit | 112 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Mcminnville Dialysis Clinic were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 22.8 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 36 |
| Readmission Rate: Lower Confidence Limit | 12.7 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Mcminnville Dialysis Clinic get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .39 (As Expected) |
| SIR: Upper Confidence Limit | 1.92 |
| SIR: Lower Confidence Limit | .02 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Mcminnville Dialysis Clinic's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 44 |
| Transfusion Rate in facility | 16.4 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 79.5 |
| Transfusion Rate: Lower Confidence Limit | 4.1 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at Mcminnville Dialysis Clinic lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 224 |
| Mortality Rate in facility | 18.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 25.7 |
| Mortality Rate: Lower Confidence Limit | 13.5 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago
Mcminnville Dialysis Clinic Location: 1524 Sparta Street, Mcminnville, Tennessee, 37110 Phone: (931) 507-5700 |
News Archive
Diabetes is growing at an alarming rate in Canada, with an estimated 3.7 million people expected to be diagnosed by 2020. It is a progressive disease that, if not properly monitored and managed over time, will lead to serious long term complications. Canadians now have a novel treatment available to help them maintain optimal blood glucose levels. Health Canada has approved Victoza (liraglutide), the first GLP-1 analogue, for once-daily administration for the treatment of adults with type 2 diabetes to improve glycemic control in combination with metformin or metformin and a sulfonylurea.
Genes responsible for our 24 hour body clock influence not only the timing of sleep, but also appear to be central to the actual restorative process of sleep, according to research published in the online open access journal BMC Neuroscience.
In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.
The European Commission has given the green light to an ambitious research project called SUNRAY: the acronym for 'Sustainable Nutrition Research for Africa in the Years to come'. The project will be implemented by a consortium of four African and five European institutions coordinated by the Institute of Tropical Medicine Antwerp.
› Verified 5 days ago